Measurement of T-kinin in rat plasma using a specific radioimmunoassay

Finbarr O'Harte, D. David Smith, Stephen J. Lanspa, J. Michael Conlon

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

T-kinin (Ile-Ser-Bradykinin) has been isolated only from the plasma of the rat and it is unclear whether the peptide, or its biosynthetic precursor, T-kininogen, circulates in the human. An NH2-terminally directed antiserum to T-kinin was raised in rabbits using an immunogen prepared by coupling the free-SH group of T-kinin extended from its COOH-terminus by a cysteinyl residue to an -NH2 group on human serum albumin. A radioimmunoassay was developed using this antiserum and 125I-labelled [Tyr10]T-kinin as tracer that was sensitive (least-detectable concentration 3 fmol/tube) and relatively specific for T-kinin (cross-reactivity with bradykinin and kallidin <1%). Treatment of rat plasma with an excess of trypsin in the presence of a kininase inhibitor generated T-kinin immunoreactivity equivalent to 455 ± 71 pmol/ml (mean ± S.E.M.; n = 9) and this immunoreactivity was eluted from a reversed-phase HPLC column as a single peak with the same retention time as synthetic T-kinin. In contrast, treatment of plasma from healthy human subjects (n = 8) and from patients (n = 8) with inflammation due to acute or chronic gastrointestinal disease under the same conditions did not generate any detectable T-kinin immunoreactivity. It is concluded, therefore, that T-kininogen, the biosynthetic precursor of T-kinin in the rat, is either absent from the plasma of human subjects or is present in a concentration <30 fmol/ml. Similarly, T-kininogen is probably not an acute phase reactant in humans.

Original languageEnglish
Pages (from-to)139-148
Number of pages10
JournalRegulatory Peptides
Volume41
Issue number2
DOIs
StatePublished - Sep 22 1992

Fingerprint

T-kinin
Radioimmunoassay
Rats
Plasmas
Kininogens
Immune Sera
Kallidin

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

Measurement of T-kinin in rat plasma using a specific radioimmunoassay. / O'Harte, Finbarr; David Smith, D.; Lanspa, Stephen J.; Michael Conlon, J.

In: Regulatory Peptides, Vol. 41, No. 2, 22.09.1992, p. 139-148.

Research output: Contribution to journalArticle

O'Harte, Finbarr ; David Smith, D. ; Lanspa, Stephen J. ; Michael Conlon, J. / Measurement of T-kinin in rat plasma using a specific radioimmunoassay. In: Regulatory Peptides. 1992 ; Vol. 41, No. 2. pp. 139-148.
@article{f6a5fd0b1c1149a7af442b3b270d68fa,
title = "Measurement of T-kinin in rat plasma using a specific radioimmunoassay",
abstract = "T-kinin (Ile-Ser-Bradykinin) has been isolated only from the plasma of the rat and it is unclear whether the peptide, or its biosynthetic precursor, T-kininogen, circulates in the human. An NH2-terminally directed antiserum to T-kinin was raised in rabbits using an immunogen prepared by coupling the free-SH group of T-kinin extended from its COOH-terminus by a cysteinyl residue to an -NH2 group on human serum albumin. A radioimmunoassay was developed using this antiserum and 125I-labelled [Tyr10]T-kinin as tracer that was sensitive (least-detectable concentration 3 fmol/tube) and relatively specific for T-kinin (cross-reactivity with bradykinin and kallidin <1{\%}). Treatment of rat plasma with an excess of trypsin in the presence of a kininase inhibitor generated T-kinin immunoreactivity equivalent to 455 ± 71 pmol/ml (mean ± S.E.M.; n = 9) and this immunoreactivity was eluted from a reversed-phase HPLC column as a single peak with the same retention time as synthetic T-kinin. In contrast, treatment of plasma from healthy human subjects (n = 8) and from patients (n = 8) with inflammation due to acute or chronic gastrointestinal disease under the same conditions did not generate any detectable T-kinin immunoreactivity. It is concluded, therefore, that T-kininogen, the biosynthetic precursor of T-kinin in the rat, is either absent from the plasma of human subjects or is present in a concentration <30 fmol/ml. Similarly, T-kininogen is probably not an acute phase reactant in humans.",
author = "Finbarr O'Harte and {David Smith}, D. and Lanspa, {Stephen J.} and {Michael Conlon}, J.",
year = "1992",
month = "9",
day = "22",
doi = "10.1016/0167-0115(92)90043-T",
language = "English",
volume = "41",
pages = "139--148",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Measurement of T-kinin in rat plasma using a specific radioimmunoassay

AU - O'Harte, Finbarr

AU - David Smith, D.

AU - Lanspa, Stephen J.

AU - Michael Conlon, J.

PY - 1992/9/22

Y1 - 1992/9/22

N2 - T-kinin (Ile-Ser-Bradykinin) has been isolated only from the plasma of the rat and it is unclear whether the peptide, or its biosynthetic precursor, T-kininogen, circulates in the human. An NH2-terminally directed antiserum to T-kinin was raised in rabbits using an immunogen prepared by coupling the free-SH group of T-kinin extended from its COOH-terminus by a cysteinyl residue to an -NH2 group on human serum albumin. A radioimmunoassay was developed using this antiserum and 125I-labelled [Tyr10]T-kinin as tracer that was sensitive (least-detectable concentration 3 fmol/tube) and relatively specific for T-kinin (cross-reactivity with bradykinin and kallidin <1%). Treatment of rat plasma with an excess of trypsin in the presence of a kininase inhibitor generated T-kinin immunoreactivity equivalent to 455 ± 71 pmol/ml (mean ± S.E.M.; n = 9) and this immunoreactivity was eluted from a reversed-phase HPLC column as a single peak with the same retention time as synthetic T-kinin. In contrast, treatment of plasma from healthy human subjects (n = 8) and from patients (n = 8) with inflammation due to acute or chronic gastrointestinal disease under the same conditions did not generate any detectable T-kinin immunoreactivity. It is concluded, therefore, that T-kininogen, the biosynthetic precursor of T-kinin in the rat, is either absent from the plasma of human subjects or is present in a concentration <30 fmol/ml. Similarly, T-kininogen is probably not an acute phase reactant in humans.

AB - T-kinin (Ile-Ser-Bradykinin) has been isolated only from the plasma of the rat and it is unclear whether the peptide, or its biosynthetic precursor, T-kininogen, circulates in the human. An NH2-terminally directed antiserum to T-kinin was raised in rabbits using an immunogen prepared by coupling the free-SH group of T-kinin extended from its COOH-terminus by a cysteinyl residue to an -NH2 group on human serum albumin. A radioimmunoassay was developed using this antiserum and 125I-labelled [Tyr10]T-kinin as tracer that was sensitive (least-detectable concentration 3 fmol/tube) and relatively specific for T-kinin (cross-reactivity with bradykinin and kallidin <1%). Treatment of rat plasma with an excess of trypsin in the presence of a kininase inhibitor generated T-kinin immunoreactivity equivalent to 455 ± 71 pmol/ml (mean ± S.E.M.; n = 9) and this immunoreactivity was eluted from a reversed-phase HPLC column as a single peak with the same retention time as synthetic T-kinin. In contrast, treatment of plasma from healthy human subjects (n = 8) and from patients (n = 8) with inflammation due to acute or chronic gastrointestinal disease under the same conditions did not generate any detectable T-kinin immunoreactivity. It is concluded, therefore, that T-kininogen, the biosynthetic precursor of T-kinin in the rat, is either absent from the plasma of human subjects or is present in a concentration <30 fmol/ml. Similarly, T-kininogen is probably not an acute phase reactant in humans.

UR - http://www.scopus.com/inward/record.url?scp=0026668774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026668774&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(92)90043-T

DO - 10.1016/0167-0115(92)90043-T

M3 - Article

VL - 41

SP - 139

EP - 148

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 2

ER -